Systematic Screening of a Glycolysis-targeting Small-molecule Library Identifies Novel Inhibitors of Fungal Morphogenesis in Candida albicans
Authors:
Preprint
Abstract
Fungal infections are an increasing global health concern, with Candida albicans emerging as a leading cause of mucosal and life-threatening systemic infections. C. albicans relies on yeast-to-hyphae transition, to establish systemic infections in the host. Our recent work demonstrated that glycolysis is a key regulator of hyphal differentiation in C. albicans (Shah et al., 2025). Leveraging this knowledge, we screened a small-molecule compound library containing glycolysis inhibitors for their ability to block fungal morphogenesis. Our systematic screen of glycolysis-targeting compounds acting on distinct enzymatic steps of glycolysis identified multiple inhibitors of glycolysis that robustly block hyphal differentiation in C. albicans without compromising its overall growth. While early glycolysis pathway inhibitors showed moderate effects, two compounds (NPD10084 and PKM2-IN-6) targeting pyruvate kinase activity emerged as the most potent inhibitors of fungal morphogenesis, completely blocking hyphal differentiation in C. albicans , in multiple filamentation-inducing conditions. Notably, these inhibitors effectively impaired biofilm formation and exhibited synergistic activity with conventional antifungal drugs, including amphotericin B and fluconazole. Furthermore, administration of NPD10084 and PKM2-IN-6 significantly improved the survival of mice in a systemic model of murine candidiasis underscoring the in vivo efficacy of these compounds. Molecular docking analysis showed stable binding of both compounds to the ATP-binding pocket of pyruvate kinase, suggesting ATP-competitive inhibition. Collectively, our study has identified novel inhibitors of fungal morphogenesis in C. albicans that target pyruvate kinase activity to block a key virulence strategy of this human fungal pathogen.Keywords
Funding Information
- Anusandhan National Research Foundation (SRG/2023/000470)
This publication has 201 references indexed in Scilit:
- Synthesis and Target Identification of Benzoxepane Derivatives as Potential Anti‐Neuroinflammatory Agents for Ischemic StrokeAngewandte Chemie International Edition, 2019
- An overview of structure, function, and regulation of pyruvate kinasesProtein Science, 2019
- Rhoifolin ameliorates titanium particle‐stimulated osteolysis and attenuates osteoclastogenesis via RANKL‐induced NF‐κB and MAPK pathwaysJournal of Cellular Physiology, 2019
- Bioactivity screening, extraction, and separation of lactate dehydrogenase inhibitors from Polygala tenuifolia Willd. based on a hyphenated strategyJournal of Separation Science, 2017
- A Potent Glucose–Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer CellsAngewandte Chemie International Edition, 2016
- Phloretin and phlorizin promote lipolysis and inhibit inflammation in mouse 3T3‐L1 cells and in macrophage‐adipocyte co‐culturesMolecular Nutrition & Food Research, 2013
- Carbon source‐induced reprogramming of the cell wall proteome and secretome modulates the adherence and drug resistance of the fungal pathogen C andida albicansProteomics, 2012
- The natural chemopreventive phytochemical R‐sulforaphane is a far more potent inducer of the carcinogen‐detoxifying enzyme systems in rat liver and lung than the S‐isomerInternational Journal of Cancer, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The metabolism of lactateNMR in Biomedicine, 1991